GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » King International Investment Ltd (HKSE:00928) » Definitions » Short Interest

King International Investment (HKSE:00928) Short Interest


View and export this data going back to 2002. Start your Free Trial

What is King International Investment Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of King International Investment's Short Interest

For the Diagnostics & Research subindustry, King International Investment's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


King International Investment's Short Interest Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, King International Investment's Short Interest distribution charts can be found below:

* The bar in red indicates where King International Investment's Short Interest falls into.



King International Investment (HKSE:00928) Business Description

Traded in Other Exchanges
N/A
Address
18 Harbour Road, Room 6307-08, 63rd Floor, Central Plaza, Wanchai, Hong Kong, HKG
King International Investment Ltd formerly Life Healthcare Group Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business and Money lending business. It generates maximum revenue from the Healthcare products and services business segment. Geographically, it derives a majority of revenue from PRC. The group is primarily a provider of genetic testing and health data analysis services.
Executives
Wei Yan 2101 Beneficial owner
Wang Mengyao 2101 Beneficial owner
Wong Yat Fung 2101 Beneficial owner
Zhou Chun Yan 2101 Beneficial owner
Pioneer Environmental International Industries Company Limited 2101 Beneficial owner
Liu Na 2201 Interest of corporation controlled by you
Wang Wen 2101 Beneficial owner
Pang Zhen 2101 Beneficial owner

King International Investment (HKSE:00928) Headlines

No Headlines